| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention refers to pharmaceutical industry, particularly to using an eucalyptus extract for making a drug preparation or a food additive for treating and/or preventing diseases and pathologies due to disturbed dopamine and/or serotonin and/or noradrenalin reuptake. The use of the eucalyptus extract for producing the drug preparation or the food additive for treating and/or preventing neurological, psychiatric pathologies and diseases and related disorders due to disturbed dopamine and/or serotonin and/or noradrenalin reuptake, wherein the eucalyptus extract contains at least one compound of formula (I) or any of its diastereoisomeric forms: wherein R1 together with carbon atoms whereto attached forms the group C=CH2, the group or and R2 means isobutyl, -isobutyl or -isobutyl group. The use of at least one compound of formula (I). The eucalyptus extract for producing the drug preparation or the food additive. The method for producing the extract. ^ EFFECT: eucalyptus extract containing the compound of formula (I) or the compound of formula (I) are effective for producing the drug preparation or the food additive for treating and/or preventing neurological, psychiatric pathologies and diseases and related disorders due to disturbed dopamine and/or serotonin and/or noradrenalin reuptake. ^ 25 cl, 3 tbl, 7 ex |
